Resources

Consumption of green leafy vegetables and fruit was associated with a lower hazard of type 2 diabetes mellitus (DM), whereas consumption of fruit juices may be associated with an increased hazard of diabetes among women, according to the results of a study.

Apple product consumers likely to have lower blood pressure, trimmer waistlines, and more nutrient dense diets according to the results of a new study.

The class of glitazone diabetes drugs offer no benefits as monotherapy compared with older, less expensive drugs, according to the authors of an analysis of data from recent clinical trials.

Despite their reputation for deadly attacks on humans and pets, alligators are wiggling their way toward a new role as potential lifesavers in medicine. Biochemists described how proteins in gator blood may provide a source of powerful new antibiotics to help fight infections associated with diabetic ulcers, severe burns, and …

Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes.

An international blood pressure study (ACCOMPLISH )comparing two single-pill drug combinations has yielded results so significant that the study has been stopped early – and the researchers say their findings might alter the way high blood pressure is treated worldwide.

Patients who slept for short or long durations experienced an increase in weight compared with those who slept for an average duration of 7 to 9 hours, according to the results of a longitudinal study.

Less weight gain, reduction of inflammation, lower cholesterol and triglycerides and lower blood sugars, all from tart cherries.

Safety review of becaplermin gel (Regranex, Johnson & Johnson) is being conducted after study results suggested an increased risk for cancer-related mortality, the US Food and Drug Administration (FDA) warned healthcare professionals last week.

The FDA has warned that more cases of lung cancers have been reported in patients treated with the inhaled insulin Exubera than in controls in clinical trials. So with this new information it looks like the end of research on inhaled insulins.